- Lobbying
- Hunter AND Price
Lobbying Arrangements Results for 'Hunter Price'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details technology research |
Vorbeck Materials
|
Edgepoint, LLC | |||
Details Support in client's interactions with the Consumer Financial Protection Bureau |
Nexus Services
|
Edgepoint, LLC | |||
Details technology research |
Cellcrypt
|
Edgepoint, LLC | |||
Details federal support and partnership for Clemson's cybersecurity program |
ADI on behalf of Clemson University
|
Edgepoint, LLC | |||
Details indoor air quality |
Paddock Industries
|
Edgepoint, LLC | |||
Details Medicare Advantage issues related to skin substitutes; Average Sales Price (ASP) skin substitutes pricing file |
Harbinger Medical Group LLC dba Tides Medical
|
The Picard Group, LLC | |||
Details H.R. 3561 the PATIENT Act of 2023, all provisions related to hospital compliance with price transparency regulations, delay of scheduled payment cuts for Disproportionate Share Hospitals, the 340B ... |
Wellstar Health System, Inc.
|
Public Strategies 360, LLC | |||
Details H.R. 5746--Addressing Whole Health in Medicare Advantage Act H.R. 5380--To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advan... |
BETTER MEDICARE ALLIANCE, INC.
|
in-house lobbying | |||
Details FDA's accelerated approval pathway; insulin price cap; H.R.830, HELP Copays Act; S.127, Pharmacy Benefit Manager Transparency Act of 2023; Pandemic and All-Hazards Preparedness Reauthorization Act ... |
Lilly USA, LLC
|
Crossroads Strategies, LLC | |||
Details Advance the use of and access to FDA-approved medications to treat addiction and mental illness in criminal justice and public health settings; pharmaceutical supply chain issues; drug pricing. Imp... |
Alkermes, Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), 340B Program, influenza, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, education... |
Genentech, Inc.
|
Crossroads Strategies, LLC | |||
Details Aviation Supply Chain, FAA Certification Standards and Aircraft Certification Offices, FAA International Validation Branch; Airworthiness Standards, Safety and Oversight, Accident Investigations, O... |
GENERAL AVIATION MANUFACTURERS ASSOCIATION
|
in-house lobbying | |||
Details Issues related to health care, the Food and Drug Administration (FDA), Rx-to-OTC switch issues, influenza, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutica... |
Sanofi US Services Inc.
|
Crossroads Strategies, LLC | |||
Details 340B drug discount program; drug pricing; importation of biopharmaceuticals; direct-to-consumer (DTC) advertising; transparency; international pharmaceutical supply chain; antimicrobial resistance ... |
Pharmaceutical Research and Manufacturers of America
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, mental health, opioid abuse, 340B Program, drug pricing, importation of biopharmaceuticals, insulin price c... |
Takeda Pharmaceuticals America, Inc.
|
Crossroads Strategies, LLC | |||
Details Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Drug pricing... |
The Children's Hospital of Philadelphia
|
ArentFox Schiff LLP | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, T... |
Merck & Co., Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, insulin price cap, and international pharmac... |
Bristol-Myers Squibb
|
Crossroads Strategies, LLC | |||
Details FDA modernization policy issues Reauthorization of newborn screening programs General issues related to rare disease and orphan drugs General issues related to health equity in rare disease and ... |
AstraZeneca Pharmaceuticals LP
|
in-house lobbying | |||
Details HR 40 ARTICLE RETRIEVED FROM : https://www.congress.gov/bill/117th-congress/house-bill/40/all-info All Information (Except Text) for H.R.40 - Commission to Study and Develop Reparation Prop... |
Fighting Apartheid Confrontation Transformation Systems, Inc.
|
in-house lobbying |